Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites-Reference-Cited by-同舟云学术

Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites

Published:2020 Issue:33 Volume:49 Page:11451-11466
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Bouché Mathilde¹²³⁴⁵^ORCID,Hognon Cécilia¹²⁶⁴⁵,Grandemange Stéphanie¹²⁷⁴⁵,Monari Antonio¹²⁶⁴⁵^ORCID,Gros Philippe C.¹²³⁴⁵^ORCID

Affiliation:

1. Université de Lorraine

2. CNRS

3. L2CM UMR 7053

4. F-54000 Nancy

5. France

6. LPCT UMR 7019

7. CRAN UMR 7039

Abstract

In this perspective, we discuss iron-complexes as drug candidates, and emphasize breakthroughs in the comprehension of their structure–activity relationship, metabolization pathways, sub-cellular localization and influence on iron homeostasis.

Funder

Université de Lorraine

Centre National de la Recherche Scientifique

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/DT/D0DT02135K

Reference177 articles.

1. Platinum drugs in the Australian cancer chemotherapy healthcare setting: Is it worthwhile for chemists to continue to develop platinums?

2. The state-of-play and future of platinum drugs

3. The side effects of platinum-based chemotherapy drugs: a review for chemists

4. A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research

5. Thirty Years of the Drug Candidate NAMI‐A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manganese(III) complexes with a tetradentate thiosemicarbazone. Structural characterization, electrochemistry, antioxidant capability, molecular docking and dynamics simulation on the potential inhibitory activity of cyclin-dependent kinase 2;Polyhedron;2024-10

2. Rational and experimental investigation of antihypotensive midodrine-Fe(III) complex: Synthesis, spectroscopy, DFT, biological activity and molecular docking;Journal of Molecular Structure;2024-09

3. Iron(III)-salophene catalyzes redox cycles that induce phospholipid peroxidation and deplete cancer cells of ferroptosis-protecting cofactors;Redox Biology;2024-09

4. Metal N-heterocyclic carbene complexes as potential metallodrugs in antitumor therapy;Coordination Chemistry Reviews;2024-09

5. Homo and heteromultimetallic complexes containing a group 8 transition metal and μ-diphosphine bridging ligands involved in anticancer research: A review;European Journal of Medicinal Chemistry;2024-08